TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Inhalation Sciences Sweden AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
11,757
|
8,148
|
6,851 |
Financial expenses |
668
|
69
|
28 |
Earnings before taxes |
-3,186
|
-8,102
|
-12,077 |
EBITDA |
-1,773
|
-7,248
|
-11,191 |
Total assets |
12,203
|
8,677
|
18,987 |
Current assets |
10,609
|
6,346
|
15,621 |
Current liabilities |
3,205
|
3,056
|
3,684 |
Equity capital |
8,701
|
5,047
|
14,308 |
- share capital |
4,075
|
3,040
|
3,308 |
Employees (average) |
8
|
9
![]() |
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.3%
|
58.2%
|
75.4% |
Turnover per employee |
1,470
|
905
|
761 |
Profit as a percentage of turnover |
-27.1%
|
-99.4%
|
-176.3% |
Return on assets (ROA) |
-20.6%
|
-92.6%
|
-63.5% |
Current ratio |
331.0%
|
207.7%
|
424.0% |
Return on equity (ROE) |
-36.6%
|
-160.5%
|
-84.4% |
Change turnover |
3,567
|
1,852
|
-520 |
Change turnover % |
44%
|
29%
|
-7% |
Chg. No. of employees |
-1
|
0
|
1 |
Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.